NewAmsterdam Pharma Company N.V.
NAMS
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 35.2 | 45.6 | 12.8 | 97.5 | 0.0 | 0.0 | |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 35.2 | 45.6 | 12.8 | 97.5 | 0.0 | 0.0 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 159.4 | 82.5 | 25.2 | 4.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 29.8 | 21.9 | 4.7 | 1.4 | |
| Depreciation & Amortization | 0.2 | 0.1 | 0.0 | 60.7 | 0.0 | 0.0 | |
| Total Operating Expenses | 238.2 | 221.9 | 197.1 | 104.5 | 29.8 | 5.4 | |
| Operating Income | -202.9 | -176.3 | -165.7 | -67.6 | -29.8 | -5.4 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 25.6 | 16.9 | 10.2 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 6.8 | 0.3 | 0.2 | 0.3 | |
| Other Expense | -18.1 | -65.3 | 5.5 | -10.5 | 1.2 | -0.3 | |
| IBT | -221.1 | -241.6 | -160.2 | -78.1 | -28.6 | -5.7 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 70.8 | 0.2 | 0.3 | |
| Net Income | -221.1 | -241.6 | -176.9 | -148.9 | -28.8 | -6.1 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-2.15 | $-1.83 | $-0.35 | $-0.07 | |
| EPS Diluted | $0.00 | $0.00 | $-2.15 | $-1.83 | $-0.35 | $-0.07 | |
| Shares Outstanding | 119.0 | 94.4 | 82.2 | 81.6 | 81.6 | 81.6 | |
| Diluted Shares Outstanding | 119.0 | 94.4 | 82.2 | 81.6 | 81.6 | 81.6 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 401.3 | 771.7 | 340.5 | 438.5 | 53.1 | 7.9 | |
| Short Term Investments | 0.0 | 62.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 401.3 | 834.2 | 340.5 | 438.5 | 53.1 | 7.9 | |
| Accounts Receivable | 5.0 | 21.3 | 1.9 | 1.9 | 4.3 | 0.0 | |
| Inventory | -5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 13.6 | 7.9 | 4.5 | 0.0 | 0.0 | 0.0 | |
| Total Current Assets | 415.0 | 863.4 | 346.8 | 448.1 | 58.9 | 9.2 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.7 | 0.7 | 0.1 | 0.1 | 0.2 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.5 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 0.0 | 0.0 | 0.1 | 0.7 | 0.0 | |
| Total Long-Term Assets | 1.2 | 1.2 | 0.3 | 83.5 | 0.9 | 0.0 | |
| Total Assets | 416.2 | 864.6 | 347.1 | 531.6 | 59.8 | 9.2 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.9 | 4.7 | 16.9 | 11.1 | 6.2 | 0.4 | |
| Short-Term Debt | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 11.7 | |
| Other Current Liabilities | 31.4 | 95.9 | 24.0 | 11.3 | 0.0 | 0.8 | |
| Current Liabilities | 42.2 | 106.9 | 49.9 | 35.5 | 9.9 | 12.8 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.3 | 0.2 | 0.0 | 0.1 | 0.1 | 0.0 | |
| Capital Leases | 0.5 | 0.4 | 0.1 | 0.1 | 0.2 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 55.2 | 107.1 | 58.7 | 47.1 | 10.0 | 12.8 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 10.4 | 13.4 | 10.2 | 599.2 | 83.9 | 2.5 | |
| Retained Earnings | -419.1 | 0.0 | -317.0 | -119.4 | -34.7 | -6.1 | |
| Comprehensive Income | 4.1 | 4.5 | 4.4 | 4.7 | 0.6 | 0.0 | |
| Total Common Equity | 361.0 | 757.5 | 288.4 | 484.5 | 49.8 | -3.6 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -212.2 | -241.6 | -176.9 | -78.1 | -28.6 | -5.7 | |
| Depreciation & Amortization | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Stock-Based Compensation | 25.7 | 33.6 | 24.6 | 3.9 | 1.0 | 0.0 | |
| Change Working Capital | -18.0 | -32.7 | 5.9 | 11.5 | 3.8 | -0.5 | |
| Change In Accounts Receivable | -7.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -10.9 | -12.9 | 5.1 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 5.1 | 82.0 | 5.2 | 70.6 | 0.0 | 0.3 | |
| Cash from Operations | -168.9 | 0.0 | -141.2 | 8.0 | -25.2 | -6.0 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.6 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | -62.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -5.2 | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | |
| Cash from Investing | -5.8 | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Debt Issued | 0.4 | 0.4 | -0.1 | 0.0 | -11.5 | 11.7 | |
| Issuance of Common Stock | 181.6 | 0.0 | 7.3 | 377.8 | 69.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 3.2 | 0.0 | 8.9 | -2.5 | 0.0 | 0.0 | |
| Cash from Financing | 189.0 | 0.0 | 8.9 | 375.2 | 69.0 | 11.3 | |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Change in Cash | 21.2 | 431.3 | -127.3 | 385.4 | 45.2 | 5.4 | |
| Closing Cash Balance | 401.3 | 771.7 | 340.5 | 438.5 | 53.1 | 7.9 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -169.5 | -159.2 | -141.2 | 8.0 | -25.2 | -6.0 | |
| Real Free Cash Flow | -195.2 | -192.9 | -165.8 | 4.0 | -26.2 | -6.0 | |
| Nacenění | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| P/E | -29.34 | -10.04 | -5.19 | -9.78 | -4.71 | -32.77 | |
| P/EG | 0.52 | -0.53 | -0.06 | 0.15 | -0.02 | 0.00 | |
| P/B | 2.62 | 3.20 | 3.18 | 0.43 | 3.48 | -52.66 | |
| P/S | 26.61 | 53.22 | 71.91 | 2.16 | 0.00 | 0.00 | |
| P/FCF | -13.49 | -15.23 | -6.50 | 25.97 | -6.87 | -31.48 | |
| P/OFC | -13.52 | -15.29 | -6.50 | 25.93 | -6.88 | -31.55 | |
| Price/EV | -10.35 | -6.85 | -3.26 | 69.92 | -3.91 | -35.40 | |
| Marže | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% | |
| EBIT Margin | -186.1% | -530.3% | -1,386.1% | -23.3% | 0.0% | 0.0% | |
| EBITDA Margin | -185.9% | -530.0% | -1,385.8% | -3.5% | 0.0% | 0.0% | |
| Operating Profit Margin | -186.1% | -386.9% | -1,298.6% | -3.5% | 0.0% | 0.0% | |
| Net Profit Margin | -90.7% | -530.3% | -1,386.4% | -22.0% | 0.0% | 0.0% | |
| Finanční zdraví | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.08 | 8.08 | 6.95 | 12.64 | 5.96 | 0.72 | |
| Quick Ratio | 21.08 | 8.08 | 6.95 | 12.64 | 5.96 | 0.72 | |
| Solvency Ratio | -0.47 | -2.25 | -3.01 | -0.45 | -3.67 | -0.45 | |
| Cash Ratio | 15.44 | 7.22 | 6.82 | 12.37 | 5.37 | 0.61 | |
| Debt To Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.26 | |
| Debt To Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.26 | |
| Financial Leverage Ratio | 1.05 | 1.14 | 1.20 | 1.10 | 1.20 | -2.58 | |
| Debt Service Coverage Ratio | -158.18 | -981.65 | -26.02 | 0.00 | 0.00 | -0.47 | |
| Interest Coverage Ratio | 0.00 | 0.00 | -24.38 | 0.00 | 0.00 | 0.00 | |
| Data na akcii | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Revenue Per Share | 0.63 | 0.48 | 0.16 | 5.06 | 0.00 | 0.00 | |
| Net Income Per Share | -1.62 | -2.56 | -2.15 | -1.11 | -2.07 | -0.32 | |
| Cash Per Share | 6.57 | 8.84 | 4.14 | 23.12 | 2.99 | 0.44 | |
| Shareholders Equity Per Share | 6.92 | 8.03 | 3.51 | 25.55 | 2.80 | -0.20 | |
| Free Cash Flow Per Share | -1.17 | -1.69 | -1.72 | 0.42 | -1.42 | -0.34 | |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Efektivita | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Effective Tax Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Receivables Turnover | 6.63 | 2.14 | 6.79 | 46.33 | 0.00 | 0.00 | |
| Payables Turnover | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Asset Turnover | 94.97 | 67.70 | 126.36 | 666.01 | 0.00 | 0.00 | |
| Working Capital Turnover Ratio | 0.13 | 0.09 | 0.04 | 0.42 | 0.00 | 0.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
